Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts
By Patrick Wingrove (Reuters) -Moderna (MRNA) topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven ...
Read moreDetails
